Your browser doesn't support javascript.
Pulmonary recovery from COVID-19 in patients with metabolic diseases: a longitudinal prospective cohort study.
Sonnweber, Thomas; Grubwieser, Philipp; Pizzini, Alex; Boehm, Anna; Sahanic, Sabina; Luger, Anna; Schwabl, Christoph; Widmann, Gerlig; Egger, Alexander; Hoermann, Gregor; Wöll, Ewald; Puchner, Bernhard; Kaser, Susanne; Theurl, Igor; Nairz, Manfred; Tymoszuk, Piotr; Weiss, Günter; Joannidis, Michael; Löffler-Ragg, Judith; Tancevski, Ivan.
  • Sonnweber T; Department of Internal Medicine II, Medical University of Innsbruck, Innsbruck, Austria. Thomas.Sonnweber@i-med.ac.at.
  • Grubwieser P; Department of Internal Medicine II, Medical University of Innsbruck, Innsbruck, Austria.
  • Pizzini A; Department of Internal Medicine II, Medical University of Innsbruck, Innsbruck, Austria.
  • Boehm A; Department of Internal Medicine II, Medical University of Innsbruck, Innsbruck, Austria.
  • Sahanic S; Department of Internal Medicine II, Medical University of Innsbruck, Innsbruck, Austria.
  • Luger A; Department of Radiology, Medical University of Innsbruck, Innsbruck, Austria.
  • Schwabl C; Department of Radiology, Medical University of Innsbruck, Innsbruck, Austria.
  • Widmann G; Department of Radiology, Medical University of Innsbruck, Innsbruck, Austria.
  • Egger A; Central Institute of Medical and Chemical Laboratory Diagnostics, University Hospital Innsbruck, Innsbruck, Austria.
  • Hoermann G; Central Institute of Medical and Chemical Laboratory Diagnostics, University Hospital Innsbruck, Innsbruck, Austria.
  • Wöll E; MLL Munich Leukemia Laboratory, Munich, Germany.
  • Puchner B; Department of Internal Medicine, St. Vinzenz Hospital, Zams, Austria.
  • Kaser S; Department of Internal Medicine II, Medical University of Innsbruck, Innsbruck, Austria.
  • Theurl I; The Karl Landsteiner Institute, Reha Zentrum Münster, Münster, Austria.
  • Nairz M; Department of Internal Medicine I, Medical University of Innsbruck, Innsbruck, Austria.
  • Tymoszuk P; Department of Internal Medicine II, Medical University of Innsbruck, Innsbruck, Austria.
  • Weiss G; Department of Internal Medicine II, Medical University of Innsbruck, Innsbruck, Austria.
  • Joannidis M; Data Analytics As a Service Tirol, Innsbruck, Austria.
  • Löffler-Ragg J; Department of Internal Medicine II, Medical University of Innsbruck, Innsbruck, Austria.
  • Tancevski I; Division of Intensive Care and Emergency Medicine, Department of Internal Medicine I, Medical University of Innsbruck, Innsbruck, Austria. michael.joannidis@i-med.ac.at.
Sci Rep ; 13(1): 2599, 2023 02 14.
Article in English | MEDLINE | ID: covidwho-2245378
ABSTRACT
The severity of coronavirus disease 2019 (COVID-19) is related to the presence of comorbidities including metabolic diseases. We herein present data from the longitudinal prospective CovILD trial, and investigate the recovery from COVID-19 in individuals with dysglycemia and dyslipidemia. A total of 145 COVID-19 patients were prospectively followed and a comprehensive clinical, laboratory and imaging assessment was performed at 60, 100, 180, and 360 days after the onset of COVID-19. The severity of acute COVID-19 and outcome at early post-acute follow-up were significantly related to the presence of dysglycemia and dyslipidemia. Still, at long-term follow-up, metabolic disorders were not associated with an adverse pulmonary outcome, as reflected by a good recovery of structural lung abnormalities in both, patients with and without metabolic diseases. To conclude, dyslipidemia and dysglycemia are associated with a more severe course of acute COVID-19 as well as delayed early recovery but do not impair long-term pulmonary recovery.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: Dyslipidemias / COVID-19 / Metabolic Diseases Type of study: Cohort study / Observational study / Prognostic study / Randomized controlled trials Topics: Long Covid Limits: Humans Language: English Journal: Sci Rep Year: 2023 Document Type: Article Affiliation country: S41598-023-29654-1

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Dyslipidemias / COVID-19 / Metabolic Diseases Type of study: Cohort study / Observational study / Prognostic study / Randomized controlled trials Topics: Long Covid Limits: Humans Language: English Journal: Sci Rep Year: 2023 Document Type: Article Affiliation country: S41598-023-29654-1